Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins.

Schepp RM, de Haan CAM, Wilkins D, Layman H, Graham BS, Esser MT, Berbers GAM.

mSphere. 2019 Apr 24;4(2). pii: e00236-19. doi: 10.1128/mSphere.00236-19.

2.

Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.

Barug D, Pronk I, van Houten MA, Versteegh FGA, Knol MJ, van de Kassteele J, Berbers GAM, Sanders EAM, Rots NY.

Lancet Infect Dis. 2019 Apr;19(4):392-401. doi: 10.1016/S1473-3099(18)30717-5. Epub 2019 Mar 27.

PMID:
30938299
3.

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy - a prospective, observational cohort study from the United Kingdom.

Rice TF, Diavatopoulos DA, Smits GP, van Gageldonk PGM, Berbers GAM, van der Klis FR, Vamvakas G, Donaldson B, Bouqueau M, Holder B, Kampmann B.

Clin Exp Immunol. 2019 Jul;197(1):1-10. doi: 10.1111/cei.13275. Epub 2019 Mar 13.

4.

Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

BMC Med Res Methodol. 2019 Jan 5;19(1):1. doi: 10.1186/s12874-018-0650-3.

5.

Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine.

van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY.

Vaccines (Basel). 2018 Dec 11;6(4). pii: E82. doi: 10.3390/vaccines6040082.

6.

Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial.

Harris VC, Haak BW, Handley SA, Jiang B, Velasquez DE, Hykes BL Jr, Droit L, Berbers GAM, Kemper EM, van Leeuwen EMM, Boele van Hensbroek M, Wiersinga WJ.

Cell Host Microbe. 2018 Aug 8;24(2):197-207.e4. doi: 10.1016/j.chom.2018.07.005.

PMID:
30092197
7.

Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.

Jonker EFF, van Ravenhorst MB, Berbers GAM, Visser LG.

Vaccine. 2018 Jun 18;36(26):3727-3732. doi: 10.1016/j.vaccine.2018.05.064. Epub 2018 May 16.

PMID:
29778515
8.

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine.

van Ravenhorst MB, den Hartog G, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

PLoS One. 2018 Apr 19;13(4):e0191261. doi: 10.1371/journal.pone.0191261. eCollection 2018.

9.

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination.

van der Lee S, van Rooijen DM, de Zeeuw-Brouwer ML, Bogaard MJM, van Gageldonk PGM, Marinovic AB, Sanders EAM, Berbers GAM, Buisman AM.

Front Immunol. 2018 Apr 4;9:681. doi: 10.3389/fimmu.2018.00681. eCollection 2018.

10.

Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease Is Enhanced by Nrf2 Agonists.

Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, Kolsum U, Beech G, Emes RD, Tcherniaeva I, Berbers GAM, Walmsley SR, Donaldson G, Wedzicha JA, Kilty I, Rumsey W, Sanchez Y, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Whyte MKB, Dockrell DH; COPDMAP.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):739-750. doi: 10.1164/rccm.201705-0903OC.

11.

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

van der Lee S, Hendrikx LH, Sanders EAM, Berbers GAM, Buisman AM.

Front Immunol. 2018 Jan 24;9:51. doi: 10.3389/fimmu.2018.00051. eCollection 2018.

12.

Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults.

van der Heiden M, de Rond LGH, van Zelm MC, Berbers GAM, Boots AMH, Buisman AM.

Front Immunol. 2018 Jan 23;9:46. doi: 10.3389/fimmu.2018.00046. eCollection 2018.

13.

An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults.

van der Heiden M, Berbers GAM, Fuentes S, van Zelm MC, Boots AMH, Buisman AM.

Front Immunol. 2018 Jan 11;8:1962. doi: 10.3389/fimmu.2017.01962. eCollection 2017.

14.

Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM.

van der Heiden M, van Ravenhorst MB, Bogaard M, Boots AMH, Berbers GAM, Buisman AM.

Exp Gerontol. 2018 May;105:101-108. doi: 10.1016/j.exger.2017.12.014. Epub 2017 Dec 26.

15.

Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.

Boef AGC, van der Klis FRM, Berbers GAM, Buisman AM, Sanders EAM, Kemmeren JM, van der Ende A, de Melker HE, Rots NY, Knol MJ.

Vaccine. 2018 Jan 8;36(3):400-407. doi: 10.1016/j.vaccine.2017.11.070. Epub 2017 Dec 6.

PMID:
29223483
16.

Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.

van der Lee S, Sanders EAM, Berbers GAM, Buisman AM.

Vaccine. 2018 Jan 4;36(2):220-226. doi: 10.1016/j.vaccine.2017.11.066. Epub 2017 Dec 1.

PMID:
29199041
17.

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection.

van der Lee S, Stoof SP, van Ravenhorst MB, van Gageldonk PGM, van der Maas NAT, Sanders EAM, Buisman AM, Berbers GAM.

Euro Surveill. 2017 Nov;22(47). doi: 10.2807/1560-7917.ES.2017.22.47.17-00011.

18.

Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults.

van der Heiden M, Duizendstra A, Berbers GAM, Boots AMH, Buisman AM.

Vaccine. 2017 Oct 9;35(42):5581-5588. doi: 10.1016/j.vaccine.2017.08.056. Epub 2017 Sep 4.

19.

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults.

van der Heiden M, Boots AMH, Bonacic Marinovic AA, de Rond LGH, van Maurik M, Tcherniaeva I, Berbers GAM, Buisman AM.

Front Immunol. 2017 Jul 19;8:817. doi: 10.3389/fimmu.2017.00817. eCollection 2017.

20.

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28.

PMID:
28668575
21.

Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM.

Vaccine. 2017 Aug 24;35(36):4753-4760. doi: 10.1016/j.vaccine.2017.06.007. Epub 2017 Jun 21.

PMID:
28647167
22.

Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination.

van der Lee S, Kemmeren JM, de Rond LGH, Öztürk K, Westerhof A, de Melker HE, Sanders EAM, Berbers GAM, van der Maas NAT, Rümke HC, Buisman AM.

Pediatr Infect Dis J. 2017 Sep;36(9):e223-e229. doi: 10.1097/INF.0000000000001620.

PMID:
28430750
23.

A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus.

Schepp RM, Berbers GA, Ferreira JA, Reimerink JH, van der Klis FR.

J Virol Methods. 2017 Mar;241:15-23. doi: 10.1016/j.jviromet.2016.12.006. Epub 2016 Dec 14.

24.

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FRM, Boland GJ, Sanders EAM, Berbers GAM, Teunis PF.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb.

25.

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.

van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA.

Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4.

PMID:
27817957
26.

Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population.

Verhagen LM, Rivera-Olivero IA, Hermsen M, Sisco MC, Maes M, Del Nogal B, Bogaert D, Berbers GA, Hermans PW, de Jonge MI, de Waard JH.

Eur Respir J. 2016 Nov;48(5):1492-1496. doi: 10.1183/13993003.00890-2016. Epub 2016 Aug 18. No abstract available.

27.

Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females.

van der Heiden M, van Zelm MC, Bartol SJW, de Rond LGH, Berbers GAM, Boots AMH, Buisman AM.

Sci Rep. 2016 May 31;6:26892. doi: 10.1038/srep26892.

28.

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2016 May 11;11(5):e0155088. doi: 10.1371/journal.pone.0155088. eCollection 2016.

29.

Stunting correlates with high salivary and serum antibody levels after 13-valent pneumococcal conjugate vaccination of Venezuelan Amerindian children.

Verhagen LM, Hermsen M, Rivera-Olivero I, Sisco MC, Pinelli E, Hermans PW, Berbers GA, de Waard JH, de Jonge MI.

Vaccine. 2016 Apr 29;34(20):2312-20. doi: 10.1016/j.vaccine.2016.03.066. Epub 2016 Mar 29.

PMID:
27036512
30.

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.

Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L.

PLoS One. 2016 Feb 10;11(2):e0148605. doi: 10.1371/journal.pone.0148605. eCollection 2016.

31.

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections.

van Twillert I, Bonačić Marinović AA, van Gaans-van den Brink JA, Kuipers B, Berbers GA, van der Maas NA, Verheij TJ, Versteegh FG, Teunis PF, van Els CA.

PLoS One. 2016 Feb 5;11(2):e0148507. doi: 10.1371/journal.pone.0148507. eCollection 2016.

32.

Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.

Prins-van Ginkel AC, Berbers GA, Grundeken LH, Tcherniaeva I, Wittenberns JI, Elberse K, Mollema L, de Melker HE, Knol MJ.

PLoS One. 2016 Jan 21;11(1):e0147437. doi: 10.1371/journal.pone.0147437. eCollection 2016.

33.

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.

Wijmenga-Monsuur AJ, van Westen E, Knol MJ, Jongerius RM, Zancolli M, Goldblatt D, van Gageldonk PG, Tcherniaeva I, Berbers GA, Rots NY.

PLoS One. 2015 Dec 10;10(12):e0144739. doi: 10.1371/journal.pone.0144739. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0155088.

34.

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?

Stoof SP, Buisman AM, van Rooijen DM, Boonacker R, van der Klis FR, Sanders EA, Berbers GA.

PLoS One. 2015 Oct 12;10(10):e0138665. doi: 10.1371/journal.pone.0138665. eCollection 2015.

35.

Response on Pneumococcal Vaccine in Preterm Infants After Neutral and Acidic Oligosaccharides Supplementation.

van den Berg JP, Westerbeek EA, van der Klis FR, Sanders EA, Berbers GA, van Elburg RM.

Pediatr Infect Dis J. 2015 Sep;34(9):976-82. doi: 10.1097/INF.0000000000000766.

PMID:
26153784
36.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
37.

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.

Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA.

Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19.

PMID:
26100925
38.

Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

van Westen E, Wijmenga-Monsuur AJ, van Dijken HH, van Gaans-van den Brink JA, Kuipers B, Knol MJ, Berbers GA, Sanders EA, Rots NY, van Els CA.

Clin Infect Dis. 2015 Aug 1;61(3):342-9. doi: 10.1093/cid/civ274. Epub 2015 Apr 1.

39.

Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model.

de Gouw D, de Jonge MI, Hermans PW, Wessels HJ, Zomer A, Berends A, Pratt C, Berbers GA, Mooi FR, Diavatopoulos DA.

PLoS One. 2014 Aug 18;9(8):e105011. doi: 10.1371/journal.pone.0105011. eCollection 2014. Erratum in: PLoS One. 2014 Nov;9(11):e113322. Gouw, Daan de [corrected to de Gouw, Daan; Jonge, Marien I de [corrected to de Jonge, Marien I].

40.

Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers.

Stoof SP, van der Klis FR, van Rooijen DM, Knol MJ, Sanders EA, Berbers GA.

PLoS One. 2014 Jun 25;9(6):e100651. doi: 10.1371/journal.pone.0100651. eCollection 2014.

41.

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.

Doedée AM, Boland GJ, Pennings JL, de Klerk A, Berbers GA, van der Klis FR, de Melker HE, van Loveren H, Janssen R.

PLoS One. 2014 Jun 4;9(6):e98175. doi: 10.1371/journal.pone.0098175. eCollection 2014.

42.

Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.

van den Berg JP, Westerbeek EA, Smits GP, van der Klis FR, Berbers GA, van Elburg RM.

PLoS One. 2014 Apr 11;9(4):e94714. doi: 10.1371/journal.pone.0094714. eCollection 2014.

43.

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR.

Euro Surveill. 2014 Feb 20;19(7):20705.

44.

Immune responses to pertussis vaccines and disease.

Edwards KM, Berbers GA.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S10-5. doi: 10.1093/infdis/jit560. Epub 2013 Oct 31. Review.

PMID:
24158958
45.

Levels and functionality of antibodies after pneumococcal conjugate vaccine in schedules with different timing of the booster dose.

van Westen E, Rodenburg GD, van Gils EJ, Tcherniaeva I, Berbers GA, Cowell L, Goldblatt D, Rots NY, van den Dobbelsteen GP, Sanders EA.

Vaccine. 2013 Dec 2;31(49):5834-42. doi: 10.1016/j.vaccine.2013.09.073. Epub 2013 Oct 10.

46.

Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses.

Scherpenisse M, Schepp RM, Mollers M, Meijer CJ, Berbers GA, van der Klis FR.

PLoS One. 2013 Sep 18;8(9):e74797. doi: 10.1371/journal.pone.0074797. eCollection 2013.

47.

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

Spijkerman J, Veenhoven RH, Wijmenga-Monsuur AJ, Elberse KE, van Gageldonk PG, Knol MJ, de Melker HE, Sanders EA, Schouls LM, Berbers GA.

JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.

PMID:
24002279
48.

Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.

van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, Lafeber HN, van Elburg RM.

PLoS One. 2013 Aug 8;8(8):e70904. doi: 10.1371/journal.pone.0070904. eCollection 2013.

49.

Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?

van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE.

Vaccine. 2013 Sep 23;31(41):4541-7. doi: 10.1016/j.vaccine.2013.07.060. Epub 2013 Aug 6.

PMID:
23933365
50.

High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.

Mollema L, Smits GP, Berbers GA, Van Der Klis FR, Van Binnendijk RS, De Melker HE, Hahné SJ.

Epidemiol Infect. 2014 May;142(5):1100-8. doi: 10.1017/S0950268813001532. Epub 2013 Aug 6.

PMID:
23915981

Supplemental Content

Loading ...
Support Center